introduction: retinal vein occlusion  is a common vascular disorder disrupting vision. two basic types of rvo are branch retinal vein occlusion and central retinal vein occlusion (crvo).  retinal vein occlusion is a multifactor process including systemic illness and local retinal factors.rvo may be associated with atherosclerotic risk factors. we analyzed the role of 2 dimensional transthoracic...

uncontrolled hypertension is well- known to give rise to systemic complications involving multiple central organs. artherosclerosis leads to damage of the retinal vessels wall, contributing to venous stasis, thrombosis and finally, occlusion. retinal vein occlusions compromise vision through development of ischaemic maculopathy, macular oedema, and rubeotic glaucoma. laser photocoagulation rema...

UNLABELLED RETINAL VEIN OCCLUSIONS PREFERRED PRACTICE PATTERN® GUIDELINES New evidence-based Retinal Vein Occlusions Preferred Practice Pattern® (PPP) guidelines, discussing the prognosis and risk factors of retinal vein occlusions and the treatment options.

introduction :   branchretinal vein occlusion (brvo), in which one of the branches of the main vein are blocked, andcentral retinal vein occlusion (crvo) in which the main vein of the eye is blocked    often occur  in elderly people and are the second to diabetes in producing disease of the vessels of the retina. the main causes of vein occlusions in middle and young aged population is not well...

Retinal vein occlusions may decrease visual acuity. There is no known therapy to treat ocular thrombosis. The authors used fondaparinux, an ultra-low-molecular-weight heparin, to treat 13 consecutive cases of recent-onset retinal vein occlusions. Two patients with renal insufficiency were not included. Eight central retinal vein occlusions and 5 branch retinal vein occlusions in 13 patients wer...

Macular edema is a common cause of visual loss in patients with retinal vein occlusions. Ozurdex(®), a dexamethasone intravitreal implant, has been shown in randomized controlled trials to reduce macular edema and improve visual acuity in patients with either branch retinal vein occlusions or central retinal vein occlusions. It was approved in the United States in 2009. Since then, new therapeu...

Retinal vein occlusions (RVO) are the second commonest sight threatening vascular disorder. Branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) are the two basic types of vein occlusion. Branch retinal vein occlusion is three times more common than central retinal vein occlusion and- second only to diabetic retinopathy as the most common retinal vascular cause of visu...

Many risk factors have been linked to retinal vein occlusions (RVOs) whether central or branch retinal vein occlusion. Ocular risk factors include glaucoma and hypermetropia. Controversy exists to whether short axial length is a risk factor for retinal vein occlusions. We report an extreme case that supports the latter hypothesis. A 33-year-old male presented with decreased visual acuity in the...

Retinal vein occlusion is a common retinal vascular disorder causing visual deterioration in the elderly. Vision-threatening complications include macular ischemia, neovascularisations, and vitreous hemorrhages. There are central and branch retinal vein occlusions as well as their ischemic and nonischemic subtypes. Branch occlusion and nonischemic cases are associated with better prognosis, oft...

Retinal vascular occlusive disorders constitute one of the major causes of blindness and impaired vision. There is marked controversy on their pathogeneses, clinical features and particularly their management. Recently, advances in clinical research added antivascular endothelial growth factor, corticosteroids and sustained-release implants to our armamentarium in the management of retinal vein...